IP Verse

Bischof & Partner competitive analysis

Latest oppositions filed by Bischof & Partner

Explore patent oppositions filed by Bischof & Partner against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP4364724
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 25, 2026
EP4185318
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 2, 2026
EP4085126
Single-Use Cell Culture Container With One Or More In-Situ Online SensorsF HOFFMANN LA ROCHEApr 2, 2025
EP3194970
Immunogenic Mutant Peptide Screening PlatformF HOFFMANN LA ROCHEApr 27, 2022
EP3060668
Vectors For Transgene ExpressionADAPTIMMUNEMar 18, 2020

Latest PTAB cases involving Bischof & Partner

Discover the latest PTAB cases involving Bischof & Partner, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bischof & Partner with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BISCHOF & PARTNER3 - - -
ADAPTIMMUNE112 - -
F HOFFMANN LA ROCHE34255 - -
REGENERON PHARMACEUTICALS53152932